Delivery Order SPE2DB20D1004-SPE2DB24FF3D6

Award Date 1/29/24
Potential Completion Date 1/30/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of LUMIGAN 0.01% eye drops, 2.5 ml, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $2,210.74. The contract is a delivery order, with a firm fixed price, and has an ultimate completion date of August 15, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of LUMIGAN 0.01% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,457.37, was made to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 21, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of LUMIGAN 0.01% eye drops. The $4,409.48 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on this order, which is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $2,552.17, is for the delivery of LUMIGAN 0.01% eye drops with an ultimate completion date of June 5, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award is for the delivery of Lumigan 0.01% eye drops, 5 mL, to the Department of Defense (DoD) Medical Supply Chain (identified as the Defense Logistics Agency (DLA) Troop Support Medical). The contract, valued at $18,603.05, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 18, 2023, with a completion date of September 19, 2023. The contract is a firm-fixed-price delivery order and does not have a set-aside designation....
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lumigan 0.01% eye drops. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with a ceiling value of $1,737.57. The award was made on September 21, 2021, with a completion date of September 22, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in the System for Award Management...
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of LUMIGAN 0.01% eye drops. The $1,307.16 firm-fixed-price contract has an ultimate completion date of April 11, 2023. This contract is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a wide range of...
This federal contract award is for the delivery of Lumigan 0.01% eye drops (5ml) to the Defense Logistics Agency (DLA). The $8,835.71 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has a completion date of September 11, 2023 and is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Lumigan 0.01% eye drops, 5 ml, to the Defense Logistics Agency (DLA) Troop Support Medical. The award was made to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price of $2,401.44 and an ultimate completion date of January 10, 2022. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of LUMIGAN 0.01% eye drops in 7.5 ml vials. The $1,469.64 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 9, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FF3D6
    Delivery Order

This federal contract award is for the delivery of LUMIGAN 0.01% eye drops, 5ml, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a potential value of $1,051.44 and a completion date of January 30, 2024. This award is not associated with any set-aside designations. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA to provide a wide range of pharmaceutical products and medical supplies in support of military treatment programs and facilities worldwide. The IDC has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025.

Generated 4/29/24, 9:58 AM